IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
Sponsors
City of Hope Medical Center, Anusha Kalbasi
Conditions
Acral MelanomaAdrenocortical CarcinomaBreast CancerHead and Neck Squamous Cell CarcinomaLung AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic MelanomaNeuroendocrine Tumors
Phase 1
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
Active, not recruitingNCT04003649
Start: 2019-12-02End: 2026-09-26Updated: 2026-05-14
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingNCT04119024
Start: 2025-10-07End: 2026-10-01Target: 18Updated: 2026-03-17